Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis

Chest

Volumn 136, Issue 5, 2009, Pages 1348-1355

  Ishii, Haruyuki ^a   Trapnell, Bruce C ^b   Tazawa, Ryushi ^c   Inoue, Yoshikazu ^d   Akira, Masanori ^e   Kogure, Yoshihito ^f   Tomii, Keisuke ^g   Takada, Toshinori ^c   Hojo, Masayuki ^h   Ichiwata, Toshio ⁱ   Goto, Hajime ^a   Nakata, Koh ^c  

^a KYORIN UNIVERSITY   (Japan)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^e National Kinki Chuo Hospital for Chest Diseases   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^g KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^h NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

ⁱ DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS PROTEINOSIS; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL;

EID: 70449367386     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0097     Document Type: Article

References (22)

1. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte-macrophage colony stimulating factor. J Exp Med 1999; 190:875-880 (Pubitemid 29451632)
2. Tanaka N, Watanabe J, Kitamura T, et al. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 1999; 442:246-250 (Pubitemid 29070842)
3. Uchida K, Nakata K, Trapnell BC, et al. High affinity autoantibodies specifically eliminate granulocyte macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2003; 103:1089-1098 (Pubitemid 38129576)
4. Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 162:658-662 (Pubitemid 30647215)
5. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of autoimmune pulmonary alveolar proteinosis patients in Japan. Am J Respir Crit Care Med 2008; 177:752-762
6. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349:2527-2539
7. Seymour JF, Presneill JJ. Pulomary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166:215-235 (Pubitemid 34765459)
8. Cordonnier C, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994; 149:788-794 (Pubitemid 24082243)
9. Dirksen U, Hattenhorst U, Schneider P, et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common β chain in children with acute myeloid leukemia associated with respiratory failure. Blood 1998; 92:1097-1103 (Pubitemid 28369021)
10. Shoji N, Ito Y, Kimura Y, et al. Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndrome: a report of four cases detected on autopsy. Leuk Res 2001; 1464:1-5 (Pubitemid 34462173)
11. Ito K, Iwabe K, Okai T, et al. Rapidly progressive pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Int Med 1994; 33:710-713 (Pubitemid 24366432)
12. Holbert JM, Costello P, Li W, et al. CT features of pulmonary alveolar proteinosis. AJR Am J Roentgenol 2001; 176:1287-1294
13. Godwin JD, Müller NL, Takasugi JE. Pulmonary alveolar proteinosis: CT findings. Radiology 1988; 169:609-613
14. Frazier AA, Franks TF, Cooke EO, et al. Pulmonary alveolar proteinosis. Radiographics 2008; 28:883-899
15. Ministry of Health, Labour, and Welfare. Protecting personal identifiable data: ethical guidelines for epidemiological research. Tokyo, Japan: Ministry of Health, Labour, and Welfare of Japan, 2002; 4:18-20
16. Akira M, Inoue G, Yamamoto S, et al. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000; 55:854-859 (Pubitemid 30744220)
17. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258:1123-1143
18. Fukuno K, Tomonari A, Tsukada N, et al. Successful cord blood transplantation for myelodysplastic syndrome resulting in resolution of pulmonary alveolar proteinosis. Bone Marrow Transplant 2006; 38:581-582 (Pubitemid 44509554)
19. Yokomura K, Chiba K, Suda T, et al. Secondary pulmonary proteinosis associated with myelodysplastic syndrome. Nihon Kokyuki Gakkai Zasshi 2002; 40:599-604
20. Numata A, Matsuishi E, Koyanagi K, et al. Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Am J Hematol 2006; 81: 107-109 (Pubitemid 43208598)
21. Tsutsumi Y, Tanaka J, Saito S, et al. Myelofibrosis after essential thrombocythemia complicated by alveolar proteinosis. Leuk Lymphoma 2003; 44:1049-1052 (Pubitemid 36417006)
22. Lee KN, Levin DL, Webb WR, et al. Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations. Chest 1997; 111:989-995